9987.T Stock - Suzuken Co., Ltd.
Unlock GoAI Insights for 9987.T
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $2.40T | $2.39T | $2.31T | $2.23T | $2.13T |
| Gross Profit | $192.23B | $185.25B | $179.69B | $167.33B | $157.84B |
| Gross Margin | 8.0% | 7.8% | 7.8% | 7.5% | 7.4% |
| Operating Income | $37.13B | $34.88B | $32.60B | $20.12B | $9.16B |
| Net Income | $34.50B | $29.02B | $20.34B | $14.39B | $7.89B |
| Net Margin | 1.4% | 1.2% | 0.9% | 0.6% | 0.4% |
| EPS | $454.58 | $357.87 | $236.46 | $163.18 | $88.51 |
Suzuken Co., Ltd., together with its subsidiaries, primarily engages in the wholesale of pharmaceuticals in Japan and internationally. The company operates in four segments: Pharmaceutical Distribution Business, Pharmaceutical Manufacturing Business, Pharmacy Business, and Healthcare-Related Services Business. The Pharmaceutical Distribution Business segment procures ethical drugs, diagnostic reagents, medical equipment and supplies, and other health-related items from manufacturers and supplies to medical institutions and pharmacies. The Pharmaceutical Manufacturing Business segment engages in the research and development, manufacturing, and marketing of ethical pharmaceuticals and diagnostic products focusing on the areas of diabetes and kidney diseases. The Pharmacy Business segment provides services through family pharmacists, as well as improves the operations of local pharmacies and provides educational support. The Healthcare-Related Services Business segment provides manufacturer support services, such as contract distribution for manufacturers; distribution of orphan drugs; and nursing care services, as well as develops, manufactures, and sells electrocardiographs, sphygmomanometers, stethoscopes, medical materials, and health promotion equipment. Suzuken Co., Ltd. also publishes medical magazines for medical institutions. The company has collaboration with Bushu Pharmaceuticals Ltd. provide contract specialty drug services. Suzuken Co., Ltd. was founded in 1932 and is headquartered in Nagoya, Japan.
Visit WebsiteEarnings History & Surprises
9987.TEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | May 11, 2026 | — | — | — | — |
Q1 2026 | Feb 12, 2026 | — | — | — | — |
Q4 2025 | Nov 13, 2025 | $131.94 | $175.46 | +33.0% | ✓ BEAT |
Q3 2025 | Aug 13, 2025 | $64.96 | $52.63 | -19.0% | ✗ MISS |
Q2 2025 | May 12, 2025 | $21.20 | $52.67 | +148.4% | ✓ BEAT |
Q1 2025 | Feb 12, 2025 | $51.64 | $137.41 | +166.1% | ✓ BEAT |
Q4 2024 | Nov 12, 2024 | $98.72 | $197.25 | +99.8% | ✓ BEAT |
Q3 2024 | Aug 9, 2024 | $51.84 | $63.91 | +23.3% | ✓ BEAT |
Q2 2024 | May 14, 2024 | $83.23 | $47.58 | -42.8% | ✗ MISS |
Q1 2024 | Feb 9, 2024 | $83.23 | $118.32 | +42.2% | ✓ BEAT |
Q4 2023 | Nov 10, 2023 | $80.55 | $151.55 | +88.1% | ✓ BEAT |
Q3 2023 | Aug 9, 2023 | — | $40.40 | — | — |
Q2 2023 | May 15, 2023 | — | $26.38 | — | — |
Q1 2023 | Feb 10, 2023 | — | $85.55 | — | — |
Q4 2022 | Nov 11, 2022 | — | $92.87 | — | — |
Q3 2022 | Aug 10, 2022 | — | $30.49 | — | — |
Q2 2022 | May 11, 2022 | — | $13.17 | — | — |
Q1 2022 | Feb 9, 2022 | — | $46.24 | — | — |
Q4 2021 | Nov 11, 2021 | — | $109.13 | — | — |
Q3 2021 | Aug 6, 2021 | — | $-4.86 | — | — |
Latest News
Frequently Asked Questions about 9987.T
What is 9987.T's current stock price?
What is the analyst price target for 9987.T?
What sector is Suzuken Co., Ltd. in?
What is 9987.T's market cap?
Does 9987.T pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to 9987.T for comparison